Literature DB >> 12412808

Simvastatin improves fracture healing in mice.

Bjorn Skoglund1, Carina Forslund, Per Aspenberg.   

Abstract

Recently, several articles have been published dealing with the anabolic effects on bone by statins. Mundy and associates discovered that several statins were able to activate the promotor of bone morphogenetic protein (BMP) 2. Additionally, oral simvastatin and lovastatin increased the cancellous bone volume in rats, presumably an effect of the increase of BMP-2. Other studies have followed, with conflicting results; some have found a positive bone metabolic effect of statins and others have not. Studies published so far have focused on osteoporosis. In this study, femur fractures were produced in 81 mature male BALB/c mice and stabilized with marrow-nailing. Forty-one mice were given a diet prepared with simvastatin, so that each mouse received an approximate dose of 120 mg/kg of body weight per day. The remaining mice received the same diet with the exception of the simvastatin. Bilateral femurs were harvested at 8, 14, and 21 days postoperatively (po), the marrow-nail was extracted, and diameters were measured. Biomechanical tests were performed on 42 mice, by way of three-point bending. Histological specimens were prepared using standard techniques. For statistical analysis, ANOVA with Scheffés post hoc test was used. At 8 days, the fracture callus was too soft for meaningful biomechanical testing. At 14 days, the callus of the simvastatin-treated mice had a 53% larger transverse area than controls (p = 0.001), the force required to break the bone was 63% greater (p = 0.001), and the energy uptake was increased by 150% (p = 0.0008). Stiffness and modulus of elasticity were not significantly affected. At 21 days, the fractures were histologically healed and the mechanical differences had disappeared. The contralateral unbroken bone showed a slight increase in transverse area because of the simvastatin treatment, but there was no significant effect on the force required to break the bone or on energy uptake. These results point to a new possibility in the treatment of fractures.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12412808     DOI: 10.1359/jbmr.2002.17.11.2004

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  30 in total

1.  The Evaluation of Therapeutic Efficacy and Safety Profile of Simvastatin Prodrug Micelles in a Closed Fracture Mouse Model.

Authors:  Yijia Zhang; Zhenshan Jia; Hongjiang Yuan; Anand Dusad; Ke Ren; Xin Wei; Edward V Fehringer; P Edward Purdue; Aaron Daluiski; Steven R Goldring; Dong Wang
Journal:  Pharm Res       Date:  2016-05-10       Impact factor: 4.200

2.  STATINS AND BONE HEALTH: A MINI REVIEW.

Authors:  Leslie R Morse; Jennifer Coker; Ricardo A Battaglino
Journal:  Actual osteol       Date:  2018 Jan-Apr

3.  Do antiosteoporotic drugs improve bone regeneration in vivo?

Authors:  Maximilian Leiblein; Dirk Henrich; Florian Fervers; Kerstin Kontradowitz; Ingo Marzi; Caroline Seebach
Journal:  Eur J Trauma Emerg Surg       Date:  2019-04-26       Impact factor: 3.693

Review 4.  Anabolic agents and bone quality.

Authors:  Tarek Sibai; Elise F Morgan; Thomas A Einhorn
Journal:  Clin Orthop Relat Res       Date:  2011-08       Impact factor: 4.176

5.  Bioerodible devices for intermittent release of simvastatin acid.

Authors:  Ju Hyeong Jeon; Mark V Thomas; David A Puleo
Journal:  Int J Pharm       Date:  2007-03-12       Impact factor: 5.875

6.  The effect of simvastatin on the proliferation and differentiation of human bone marrow stromal cells.

Authors:  Ki Hyun Baek; Won Young Lee; Ki Won Oh; Hyun Jung Tae; Jung Min Lee; En Jung Lee; Je Ho Han; Moo Il Kang; Bong Yun Cha; Kwang Woo Lee; Ho Young Son; Sung Koo Kang
Journal:  J Korean Med Sci       Date:  2005-06       Impact factor: 2.153

7.  Atorvastatin enhances bone density in ovariectomized rats given 17beta-estradiol or human parathyroid hormone(1-34).

Authors:  Tetsuya Kawane; Shinichi Terashima; Izuru Kurahashi; Toru Yanagawa; Hiroshi Yoshida; Noboru Horiuchi
Journal:  Endocrine       Date:  2004-07       Impact factor: 3.633

8.  Simvastatin induces estrogen receptor-alpha (ER-alpha) in murine bone marrow stromal cells.

Authors:  Chunli Song; Jingying Wang; Quansheng Song; Xu Li; Zhongqiang Chen; Qingjun Ma; Zhongjun Liu; Hongti Jia; Gengting Dang
Journal:  J Bone Miner Metab       Date:  2008-05-11       Impact factor: 2.626

9.  Alternating release of different bioactive molecules from a complexation polymer system.

Authors:  Ju Hyeong Jeon; David A Puleo
Journal:  Biomaterials       Date:  2008-06-02       Impact factor: 12.479

10.  Simvastatin and zinc synergistically enhance osteoblasts activity and decrease the acute response of inflammatory cells.

Authors:  Maryam Montazerolghaem; Yi Ning; Håkan Engqvist; Marjam Karlsson Ott; Maria Tenje; Gemma Mestres
Journal:  J Mater Sci Mater Med       Date:  2015-12-24       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.